(Q85072332)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

0 references

0 references

1 reference

Jeffrey W Molloy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Christopher J Calcagno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Christopher D Williams

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Frances J Jones

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Dawn M Torres

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Stephen A Harrison

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

22 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

429-436

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

Alcohol, smoking, coffee, and cirrhosis

14 February 2020

cites work

1 reference

7 January 2021

Unexpected effects of coffee consumption on liver enzymes.

1 reference

7 January 2021

Coffee, caffeine, and the risk of liver cirrhosis

1 reference

7 January 2021

Coffee, cirrhosis, and transaminase enzymes

1 reference

7 January 2021

Does coffee protect against liver cirrhosis?

1 reference

7 January 2021

Coffee intake and mortality from liver cirrhosis

1 reference

7 January 2021

Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States

1 reference

7 January 2021

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

1 reference

7 January 2021

Increased caffeine consumption is associated with reduced hepatic fibrosis

1 reference

7 January 2021

Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study

1 reference

7 January 2021

Prevalence and trends in obesity among US adults, 1999-2008

1 reference

7 January 2021

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

7 January 2021

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

7 January 2021

Long-term follow-up of patients with nonalcoholic fatty liver

1 reference

7 January 2021

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

7 January 2021

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

1 reference

7 January 2021

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

1 reference

7 January 2021

Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer

1 reference

7 January 2021

Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins

1 reference

7 January 2021

A position statement on NAFLD/NASH based on the EASL 2009 special conference

1 reference

7 January 2021

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

7 January 2021

Antioxidative activities of aroma extracts isolated from natural plants

1 reference

7 January 2021

The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat.

1 reference

7 January 2021

Elevation of glutathione levels by coffee components and its potential mechanisms

1 reference

7 January 2021

Placental glutathione S-transferase (GST-P) induction as a potential mechanism for the anti-carcinogenic effect of the coffee-specific components cafestol and kahweol.

1 reference

7 January 2021

Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species

1 reference

7 January 2021

Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation

1 reference

7 January 2021

Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.24731

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21987293%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference